Abstract:A series of spiro-quinazolinone scaffolds were constructed based on the bioactivity of quinazolinone and the inherent feature of spirocycle to design novel chitin synthase inhibitors that possess mode of action different from that of the currently used antifungal agents. Among them, the spiro[thiophen-quinazolin]-one derivatives containing α, β-unsaturated carbonyl fragments had shown inhibitory activities against chitin synthase and antifungal activities. The enzymatic experiments showed that among the sixteen compounds, compounds 12d, 12g, 12j, 12l and 12m exhibited inhibitions against chitin synthase with IC50 values of 116.7 ± 19.6 μM, 106.7 ± 14.2 μM, 102.3 ± 9.6 μM, 122.7 ± 22.2 μM and 136.8 ± 12.4 μM, respectively, which were comparable to that of polyoxin B (IC50 = 93.5 ± 11.1 μM). The assays of enzymatic Kinetic parameters showed that compound 12g was a non-competitive inhibitor of chitin synthase. The antifungal assays showed that compounds 12d, 12g, 12j, 12l and 12m exhibited a broad-spectrum of antifungal activity against the four strains tested in vitro. In which, compounds 12g and 12j had stronger antifungal activity against four tested strains than that of polyoxin B and similar to that of fluconazole, while compounds 12d, 12l and 12m showed antifungal activity comparable to that of polyoxin B against four tested strains. Meanwhile, compounds 12d, 12g, 12j, 12l and 12m exhibited good antifungal activity against fluconazole-resistant and micafungin-resistant fungi variants with MIC values ranging from 4 to 32 μg/mL while the MIC values of reference drugs were above 256 μg/mL. Furthermore, the results of drug-combination experiments showed that compounds 12d, 12g, 12j, 12l and 12m had synergistic or additive effects with fluconazole or polyoxin B. The results of sorbitol protection experiment and the experiment of antifungal activity against micafungin-resistant fungi further demonstrated that these compounds target chitin synthase. The result of cytotoxicity assay showed that compound 12g had low toxicity toward human lung cancer A549 cells and the ADME analysis in silico displayed that compound 12g possessed promising pharmacokinetic properties. The molecular docking indicated that compound 12g formed multiple hydrogen bond interactions binding to chitin synthase, which might be conductive to increasing the binding affinity and inhibiting the activity of chitin synthase. The above results indicated that the designed compounds were chitin synthase inhibitors with selectivity and broad-spectrum antifungal activity and could be act as the lead compounds against drug-resistant fungi.

The discovery of novel antifungal scaffolds by structural simplification of the natural product sampangine

Discovery of Simplified Sampangine Derivatives As Novel Fungal Biofilm Inhibitors.

Scaffold Hopping of Sampangine: Discovery of Potent Antifungal Lead Compound Against Aspergillus Fumigatus and Cryptococcus Neoformans.

Strategies in the Discovery of Novel Antifungal Scaffolds

Discovery of novel simplified isoxazole derivatives of sampangine as potent anti-cryptococcal agents.

An Efficient Synthesis and Antifungal Evaluation of Natural Product Streptochlorin and Its Analogues.

New Scaffold for Angiogenesis Inhibitors Discovered by Targeted Chemical Transformations of Wondonin Natural Products

Discovery of Novel Pimprinine and Streptochlorin Derivatives As Potential Antifungal Agents

Discovery of Novel Simplified Sampangine Derivatives with Potent Antifungal Activities against Cryptococcal Meningitis.

Design, synthesis, and mechanism study of novel tetrahydroisoquinoline derivatives as antifungal agents

Antifungal Function Oriented Scaffold Hopping for the Discovery of Oxazolyl-oxazoline As a Novel Model Against Fusarium Graminearum.

Scaffold Diversity Inspired by the Natural Product Evodiamine: Discovery of Highly Potent and Multitargeting Antitumor Agents

Synthesis, antifungal activity, 3D-QSAR, and molecular docking study of novel anethole-derived hydroxamate compounds

Design and Synthesis of Antifungal Benzoheterocyclic Derivatives by Scaffold Hopping

Diversity-oriented synthesis and antifungal activities of novel pimprinine derivative bearing a 1,3,4-oxadiazole-5-thioether moiety

Molecular Docking, Design, Synthesis and Antifungal Activity Study of Novel Triazole Derivatives

Structural Optimization of the Natural Product: Discovery of Almazoles C-D and Their Derivatives as Novel Antiviral and Anti-phytopathogenic Fungus Agents

A target and efficient synthetic strategy for structural and bioactivity optimization of a fungal natural product

Discovery of Chiral Diamine Derivatives Containing 1,2-Diphenylethylenediamine As Novel Antiviral and Fungicidal Agents.

Design, synthesis and biological evaluation of novel spiro-quinazolinone derivatives as chitin synthase inhibitors and antifungal agents

Discovery of the leinamycin family of natural products by mining actinobacterial genomes